Pedro T Ramirez (@pedroramirezMD) / X

Pedro T Ramirez

3,275 posts

Pedro T Ramirez

@pedroramirezMD

Professor of Gynecologic Oncology and Chair of Obstetrics & Gynecology Houston Methodist Hospital. All tweets are my own.

Houston, TX

Joined June 2017

Pedro T Ramirez
@pedroramirezMD
Mar 1, 2023
It has been an amazing journey (25 years) and so proud to have shared my career @MDAndersonNews with such inspiring leaders, colleagues and trainees! I am looking forward to this new chapter as Chair Department OBGYN at Houston Methodist Hospital @MethodistHosp THANK YOU!!
Nicole D. Fleming MD
@nicoleflemingmd
Mar 1, 2023
Wonderful morning celebrating the retirement of @pedroramirezMD @MDAndersonNews with an outstanding lecture by our friend Dr Mariani @MayoClinic! #gyncsm
36K
Pedro T Ramirez
@pedroramirezMD
Jun 30, 2021
AMAZING NEWS! Our new Impact Factor is 3.44!!! Thank you all on our team for your amazing work! @IJGConline @IJGCfellows @ESGO_society @IGCSociety @MDAndersonNews
Pedro T Ramirez
@pedroramirezMD
Jun 1, 2024
Extremely proud to see the FINAL analysis of the LACC trial @JCO_ASCO Worse OS at 4.5 years for #MIS Rates of carcinomatosis as recurrence 26% for MIS vs 0% for open surgery!! @MethodistHosp @IGCSociety @ESGO_society @IJGConline @IJGCfellows
Esra Bilir, MD, MSc
@esragbilir
Jun 1, 2024
📥LACC Trial: Final Analysis on Overall Survival Comparing Open vs Minimally Invasive Radical Hysterectomy for Early-Stage #CervicalCancer @ESGO_society @ENYGO_official @OncoAlert @gyncsm @GynMe4 @pedroramirezMD @RParejaGineOnco @FIGOHQ @AndreasObermair ascopubs.org/doi/pdf/10.120…
7.2K
Pedro T Ramirez
@pedroramirezMD
Jun 28, 2023
Extremely proud of the amazing work by our entire team! Grateful for the dedication to excellence by the Editorial Team!! Congratulations to all!! Thank you to our readers and contributors! @IJGConline @IJGCfellows @IGCSociety @ESGO_society @GynMe4
IJGC
@IJGConline
Jun 28, 2023
Thrilled to announce our #new #IJGC #ImpactFactor! Huge congratulations to the entire team and to our supporters for this amazing feat! 🎉🥂 @pedroramirezMD @JayrajAarthi @AndreFernandes2 @agz_eriksson @HsuMd @IGCSociety @ESGO_society @ENYGO_official @IGCANetwork
7.4K
Pedro T Ramirez
@pedroramirezMD
Feb 29, 2024
A new era in gynecologic oncology has begun! No more radicals for select low-risk patients #cervical #cancer Truly honored and thank you @NEJM @IJGConline @IJGCfellows @ESGO_society @IGCSociety @SGO_org @ENYGO_official @myESMO @MethodistHosp
NEJM
@NEJM
Feb 28, 2024
Replying to @NEJM
Editorial: When Less Is More — The Importance of Patient Selection nej.md/3SXzEPH
6.7K
Pedro T Ramirez
@pedroramirezMD
Aug 17, 2022
Extremely proud and honored to be the recipient of this award! Mentoring so many trainees in the US and internationally over the years has been a privilege! @MDAndersonNews @IJGConline @IJGCfellows @ESGO_society @IGCSociety @SGO_org @ENYGO_official @GynMe4
IGCS
@IGCSociety
Aug 17, 2022
Congratulations to our #IGCS2022 Outstanding Achievement in Gynecologic Oncology Surgery Award recipient Dr. Pedro T. Ramirez! @pedroramirezMD exemplary works as a surgeon, researcher & mentor have certainly advanced #GynCancer surgical care Read more: tinyurl.com/PedroTRamirez
Pedro T Ramirez
@pedroramirezMD
Jun 29, 2020
We are extremely happy to announce that the new Impact Factor for @IJGConline was announced today and it has increased from 1.7 to 2.03!! This reflects the tremendous work and dedication of an amazing team! Thank you all!! @IGCSociety @ESGO_society @IJGCfellows @GynMe4
Pedro T Ramirez
@pedroramirezMD
Aug 12, 2022
Honored to receive this award and so grateful for all the support and mentorship of so many along my academic career! Thank you to all who gave of their time and effort to teach me and inspire me! @MDAndersonNews @IGCSociety @ESGO_society @SGO_org @IJGCfellows @GynMe4 #IGCS2022
IGCS
@IGCSociety
Aug 12, 2022
Please join us in celebrating the #IGCS2022 Award recipients! These individuals (and one organization) are an inspiration to us all. Their exemplary work and passion for improving the #GynOnc community deserves global recognition and praise. Learn more: igcs.org/awards/
Pedro T Ramirez
@pedroramirezMD
Jun 2, 2023
#SHAPE! Tomorrow at #ASCO!! No more radicals for <2 cms!!! Let’s wait and see! @ASCO @IJGConline @IJGCfellows @ESGO_society @IGCSociety @SGO_org @MethodistHosp
3.2K
Pedro T Ramirez
@pedroramirezMD
Sep 2, 2023
Such an honor to present at the Annual Meeting of Surgical Oncology in Mexico! #CervicalCancer @IJGConline @IJGCfellows @IGCSociety @ESGO_society @HMethodistMD @MethodistHosp
Guillermo Moreno Flores, MD, MSc
@g_morenoflores
Sep 2, 2023
🇲🇽 a learning day with the expert in gynecology oncology #Gynecology #Oncology #ConCerv #Shape #LACC #GOG278 #CervicalCancer #Cancer @pedroramirezMD @IJGConline @IGCSociety @g_morenoflores #DrGMoreno
4K
Pedro T Ramirez
@pedroramirezMD
Dec 31, 2023
Wishing all a very Happy New Year 2024! So excited for our journal @IJGConline Truly grateful to all who continue to support our team! Thank you to all members of Editorial Team and our @IJGCfellows and to our societies @IGCSociety @ESGO_society Happy 2024!! @MethodistHosp
IJGC
@IJGConline
Dec 31, 2023
🥂 Cheers to a prosperous and joyful 2024!🥂 ✨Wishing you love and happiness throughout the year✨ 🎆Happy New Year!🎆 @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @agz_eriksson @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4
00:00
2.8K
Pedro T Ramirez
@pedroramirezMD
Oct 5, 2022
Nothing new here!…Of course patients >3 cycles do worse not because of surgery but because if they would have had a good response at 3 then you would have operated then! Let’s truly explore this: IDS after 3 vs after 6 in all patients who had a good response after 3! @SGO_org
@GynOncJnls
@gynoncjnls
Oct 4, 2022
French 🇫🇷 study finds #ovarian #cancer patients treated by delayed IDS have worse progression free survival than after standard IDS (3-4 NACT cycles) 🚨 @SGO_org @IGCSociety @ESGO_society @ASCO @myESMO @OncoAlert @Gyne_Oncology @GOG sciencedirect.com/science/articl…
Pedro T Ramirez
@pedroramirezMD
Dec 24, 2022
No survival difference between open vs MIS in high risk endometrial cancer @greenjrnl @ESGO_society @ENYGO_official @IJGConline @IJGCfellows @IGCSociety @MDAndersonNews @MayoClinic
The Green Journal
@greenjrnl
Dec 23, 2022
In high-risk endometrial #cancer, minimally invasive and open surgery resulted in similar survival. ow.ly/Mjux30ssXEZ
8.1K
Pedro T Ramirez
@pedroramirezMD
Jun 21, 2023
NOT a good step in the right direction! Sorry but NOT the best moment for @FIGO Let’s make the staging as confusing as possible and as impractical as possible for low and middle income countries!#EndometrialCancer @IGCSociety @ESGO_society @IGCSociety @SGO_org
Fabio Martinelli
@DrFMartinelli
Jun 20, 2023
New @FIGO staging of #endometrialCancer: doi.org/10.1002/ijgo.1… @ESGO_society @IGCSociety @OncoAlert @gyncsm @pedroramirezMD @leitaomd @AndreasObermair @RParejaGineOnco @GynMe4 @ENYGO_official @IJGCfellows a big change 🤯
7K